4//SEC Filing
Alexander Kristen 4
Accession 0001127602-25-007540
CIK 0001062822other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:33 PM ET
Size
15.7 KB
Accession
0001127602-25-007540
Insider Transaction Report
Form 4
Alexander Kristen
VP, Finance and Accounting
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-02-28−19,887→ 39,773 total→ Common Stock (19,887 underlying) - Exercise/Conversion
Common Stock
2025-02-28+15,926→ 74,343 total - Exercise/Conversion
Common Stock
2025-02-28+10,617→ 58,417 total - Exercise/Conversion
Common Stock
2025-02-28+19,887→ 94,230 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−15,926→ 15,927 total→ Common Stock (15,926 underlying) - Tax Payment
Common Stock
2025-02-28$0.67/sh−17,862$11,968→ 76,368 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−10,617→ 0 total→ Common Stock (10,617 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001878867
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:33 PM ET
- Size
- 15.7 KB